| |
Continuing Education Credit
Bladder Cancer: Diagnosis, Markers and Treatment
Beyond B: The Changing HIV-1 Virus and its Implications for Diagnostics and Patient Management
Fragile X Syndrome: Premature Ovarian Failure and Molecular Diagnosis
HLA and Disease Associations: An Update
Fragile X Carrier Screening: Considerations for Population-Based Screening in the OBGYN Practice
Experiences with HER2 Testing for Breast Cancer
Lean Opportunities in the Molecular Diagnostic Laboratory
HIV Genetic Diversity: Implications for Clinical Care and Diagnostic Testing
Rapid Influenza Testing: What the Clinician Needs to Know
Is it Time for Population-Based Fragile X Screening?
Chronic Kidney Disease: Role of eGFR in Detection, Evaluation and Management
Guiding Therapy Decisions for Hematological Malignancies with Molecular Genetic Testing
HLA: Tools and Strategies for Sequence Base Typing
The Reality of Real-Time PCR
Genetics of Myeloma: Clinical Implications
Microarrays as a Diagnostic Tool for Pre/Postnatal Applications
HER-2 as a Target for the Adjuvant Treatment of Breast Cancer
|